<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Can Regenerative Medicine Generate Returns?</title>
	<atom:link href="http://blog.pharmtech.com/2009/07/17/can-regenerative-medicine-generate-returns/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.pharmtech.com/2009/07/17/can-regenerative-medicine-generate-returns/</link>
	<description>The blog of Pharmaceutical Technology magazine</description>
	<lastBuildDate>Thu, 09 May 2013 23:30:55 -0400</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Lindsay S</title>
		<link>http://blog.pharmtech.com/2009/07/17/can-regenerative-medicine-generate-returns/comment-page-1/#comment-17649</link>
		<dc:creator>Lindsay S</dc:creator>
		<pubDate>Tue, 21 Jul 2009 13:21:07 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmtech.com/?p=1543#comment-17649</guid>
		<description>You raise an interesting question on ROI.  Many of the medicines that will improve and save lives in the next 50 years will be based on stem cells and other new entities.  But will these medicines be able to generate sufficient ROI?  I think the answer is yes, if we are successful at reinventing the clinical trial.  The 1960s-era path to drug approval – which the FDA and biopharma still trod – must become much more efficient while maintaining high levels in patient safety.  You may be interested in checking out this white paper “Reinventing the Clinical Trial” http://www.quintiles.com/elements/media/white-papers/reinventing-clinical-trial.pdf</description>
		<content:encoded><![CDATA[<p>You raise an interesting question on ROI.  Many of the medicines that will improve and save lives in the next 50 years will be based on stem cells and other new entities.  But will these medicines be able to generate sufficient ROI?  I think the answer is yes, if we are successful at reinventing the clinical trial.  The 1960s-era path to drug approval – which the FDA and biopharma still trod – must become much more efficient while maintaining high levels in patient safety.  You may be interested in checking out this white paper “Reinventing the Clinical Trial” <a href="http://www.quintiles.com/elements/media/white-papers/reinventing-clinical-trial.pdf" rel="nofollow">http://www.quintiles.com/elements/media/white-papers/reinventing-clinical-trial.pdf</a></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Symposier</title>
		<link>http://blog.pharmtech.com/2009/07/17/can-regenerative-medicine-generate-returns/comment-page-1/#comment-17424</link>
		<dc:creator>Symposier</dc:creator>
		<pubDate>Sat, 18 Jul 2009 02:27:56 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmtech.com/?p=1543#comment-17424</guid>
		<description>Hopefully it will, I find Tissue engineering as part of Regenerative Medicine very helpful for two very important reasons: people can have new skin in case they need it due to accidents and animal testing could be stopped. Physicians interested in this techniques should consider to attend the &quot;2nd TERMIS World Congress&quot; that will cover those topics. For more information visit the next link: http://www.symposier.com/events/viewevent/256/2nd-TERMIS-World-Congress</description>
		<content:encoded><![CDATA[<p>Hopefully it will, I find Tissue engineering as part of Regenerative Medicine very helpful for two very important reasons: people can have new skin in case they need it due to accidents and animal testing could be stopped. Physicians interested in this techniques should consider to attend the &#8220;2nd TERMIS World Congress&#8221; that will cover those topics. For more information visit the next link: <a href="http://www.symposier.com/events/viewevent/256/2nd-TERMIS-World-Congress" rel="nofollow">http://www.symposier.com/events/viewevent/256/2nd-TERMIS-World-Congress</a></p>
]]></content:encoded>
	</item>
</channel>
</rss>
